PaxVax (United States)

Institution (Company)

Homepage ROR

Also Known As

PaxVax (United States)

102

Publications

7.7K

Citations

Authors

Concepts

About

PaxVax (United States) is a company institution in Redwood City, United States known for medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	11	894
2	Natural Sciences	2	2	66
3	Biology	2	2	66
4	Engineering	1	1	36
5	Biochemistry	1	1	24

PaxVax (United States)

102

Publications

7.7K

Citations

Page 1

	Year	Citations
Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor Katherine Basore, Arthur S. Kim, Christopher A. Nelson, Cell Virus StructureMolecular VirologyMedicineMolecular BiologyVirology	2019	193
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With<i>Vibrio cholerae</i>O1 El Tor Wilbur H. Chen, Mitchell B. Cohen, Beth D. Kirkpatrick, Clinical Infectious Diseases	2016	186
Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family Donald B. Smith, Paul Becher, Jens Bukh, Journal of General Virology	2016	169
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study Marc Gurwith, Michael Lock, Eve M. Taylor, The Lancet Infectious Diseases	2013	154
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV‐1 gp120 Vaccine Peter B. Gilbert, Maggie Haitian Wang, Terri Wrin, The Journal of Infectious Diseases	2010	128
Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults Jeffrey S. Kennedy, Marc Gurwith, C. L. Dekker, The Journal of Infectious Diseases	2011	103
Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin Jeff Alexander, Simone Visosky Ward, Jason Mendy, PLoS ONE	2012	62
INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies Baoling Ying, Károly Tóth, Jacqueline F. Spencer, Cancer Gene Therapy Biodistribution StudiesNeurovirologyImmunologyViral PathogenesisPathology	2009	59
Protein nanovaccine confers robust immunity against Toxoplasma Kamal El Bissati, Ying Zhou, Sara M. Paulillo, npj Vaccines	2017	58
Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge Diego A. Espinosa, Jason Mendy, Darly J. Manayani, EBioMedicine	2017	57

Page 1